CYP2D6	iso-enzyme 2D6 of the cytochrome P450 system
EFPIA	European Federation of Pharmaceutical Industry Associations
EU	European Union
IASP	International Association for the Study of Pain
IMI	Innovative Medicines Initiative (of the EU)
iPSC	human induced pluripotent stem cell
MOR	µ-opioid receptor
NeuPSIG	Neuropathic Pain Special Interest Group (of the IASP)
PK	pharmacokinetic(s)
SmPC	Summary of Product Characteristics
Tmax	time to peak plasma concentration
t1/2	elimination half-life
Nomenclature
BioPain	a subproject of the IMI-PainCare project, which is a consortium of researchers from academia, hospitals, small-medium sized enterprises, patient organizations, pain societies and the pharmaceutical industry that combines and mutually shares expertise. Its goal is fulfilment of the objectives of Call H2020-JTI-IMI2-10, topic 3.
Call H2020-JTI-IMI2-10, topic 3	a request for research proposals issued by the Innovative Medicines Initiative of the European Union and EFPIA in the framework of the Horizon 2020 pro-gramme.